Previous studies have demonstrated that CCL18 released by tumor-associated macrophages induced EndMT in endothelial cells, altering HUVEC morphology, suppressing VE-cadherin expression and increasing the levels of vimentin and fibronectin. The gene discussed is CDH5; the disease is neoplasm.